Effect of Vitamin D3 Supplementation on the severity of Stress Urinary Incontinence (SUI) in premenopausal wome
Not Applicable
Recruiting
- Conditions
- Stress Urinary Incontinence.Stress incontinence (female) (male)N39.3
- Registration Number
- IRCT20190724044318N2
- Lead Sponsor
- Kerman University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
Age : 40 to 49 years.
Serum level of vitamin D3 less than 30 ng/ml
Confirmation of the diagnosis of stress urinary incontinence by a physician
Having a telephone line to follow up the intervention
Having at least literate
Exclusion Criteria
Use of participants from treatments other than the recommended treatment
Any disorder that prevents the absorption of vitamin D3. Such as inflammatory bowel disease (IBD) .
Chronic diabetes
Chronic liver or kidney disease
Hysterectomy
History of neoplasia Urinary-genital system
Any neurological disease that affects the urinary system or bowel movements, including multiple sclerosis
People who have used estrogen or progesterone in the last 6 months.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Stress Urinary Incontinence. Timepoint: Before the intervention and 4th – 8th and 12th weeks of the intervention. Method of measurement: ICIQ-SF standard questionnaire.
- Secondary Outcome Measures
Name Time Method